However, we did not attempt to control thiourea bond formation during Df-Bz-NCS conjugation, since the radiopharmaceutical’s affinity for FAP and the large Bmax observed with the U87MG cell line was considered sufficient for effective tumor targeting [48]. The gene discussed is FAP; the disease is neoplasm.